GENIUS Venture Capital GmbH :: English - Page 26 of 27

Venture capital for

technology companies in the

Federal State Mecklenburg-Western Pomerania
SonoBeacon GmbH

Ultrasonic signals for
location-based services,
content and interactions
SensID GmbH

Tailor-made

reference material

and services for

molecular diagnostics
Pydro GmbH

Energy-autonomous
sensorsand valves
for intelligent
water infrastructures
PRIMACYT Cell Culture

Technology GmbH

Serum-free cell cultures for
pharmacological and toxicological
assays

GENIUS

Regional venture capitalist for MV
Management support & network
Partnership for a time

Fokus

Teams of founders & innovative startups
Startup & growth stage
Fast-growing sectors

Investment

Equity holding
Co-investment with private investors up to 1.5 million euros

In 1998, GENIUS Venture Capital GmbH was established on the initiative of the Federal State of Mecklenburg-Western Pomerania. It is a subsidiary of Technologie- und Gewerbezentrum e.V. Schwerin/Wismar. We fund innovation-driven technology companies in their startup or early growth stage. We are managing venture capital funds on behalf of the Ministry of Economics, Infrastructure, Tourism and Employment of the State Mecklenburg-Western Pomerania.

Venture Capital Fonds MV GmbH

EFRE Fond

Start: 12/2015
Status: Investment phase
Fund volume under management: 15 million euros
Focus: innovative & growth-orientated SME
Stage: Seed, startup and early growth stage
Type: Open equity holdings, combination with silent partnership or convertible loans possible
Specific characteristics: Co-investment with private investors
Investor: State of Mecklenburg-Western Pomerania (EFRE funds)
Investment principles: Download (in German only)

Ministerium für Wirtschaft, Bau und Tourismus MV

Europäischer Fonds für Regionale Entwicklung (EFRE)

We offer more than just equity for young technology companies.

We actively support the development of your company, we advise you on strategic business-related matters and our network is at your service.

We expect you, as a founder, to have a clear vision of your company and a focused strategy to achieve your business goals. You need to have the necessary know-how and sector-specific knowledge as well as the potential to successfully build and lead a company. Furthermore, we expect you to support your own share of the financing by high personal and financial commitment for the company.

We invest, normally together with independent private investors, in technology-orientated micro and small-sized companies in their seed, startup or early growth stage. The headquarters or significant establishment of the company must be located in the State Mecklenburg-Western Pomerania.

Focus & Criteria

Investment process

Contact & Preselection

We analyze your executive summary or business plan and we check whether we suit each other basically.

Positive preliminary decision

Due Diligence

We will get to know each other personally and we examine the sustainability of your business model. In case of a positive result we undertake a careful and comprehensive analysis (due diligence).

Fundamental investment decision

Investment negotiation process

The business/company valuation derived hereof will serve as a basis for the following contract negotiations and the draft of the investment agreement.

Contract signing

Equity holding

As part of our investment we support your company as strategic partner and work together with you on the increase of the value of your company.

Management support

Exit

In coordination with you, we seek to sell our shares in the company within an appropriate period of time (generally 5 to 10 years).

A partnership for a time

1. Contact & Preselection

We analyze your executive summary or business plan and we check whether we suit each other basically.

Positive preliminary decision:

2. Due Diligence

We will get to know each other personally and we examine the sustainability of your business model. In case of a positive result we undertake a careful and comprehensive analysis (due diligence).

Fundamental investment decision:

3. Investment negotiation process

The business/company valuation derived hereof will serve as a basis for the following contract negotiations and the draft of the investment agreement.

Contract signing:

4. Equity holding

As part of our investment we support your company as strategic partner and work together with you on the increase of the value of your company.

Management support:

5. Exit

In coordination with you, we seek to sell our shares in the company within an appropriate period of time (generally 5 to 10 years).

A partnership for a time

Team

Portfolio (Abstract)

Private investors

We are very much interested to realize our investments at the level of the technology companies together with independent private investors. We may act as lead investor or as co-investor. That decision will be freely and personally exercised by each investor.

You are a business angel or an institutional investor? Please, contact us and share your investment criteria with us. We will introduce you to interesting companies that fit your criteria.

Partner

Bundesverband der Kapitalbeteiligungsgesellschaften

High-Tech Gründerfonds

KfW Bankengruppe

German Accelerator

High-Tech Gründerfonds

BAND

Life Science Nord

Portfolio company news (in German only)

Bionas Signs new Sales Representative for the U.S. and Appoints Managing Director
09/20/2007
Bionas GmbH, a specialist for in vitro profiling of cellular metabolic activity, is pleased to announce that Dr. Carsten Haber will be joining its team as technical sales representative for the Bionas® 1500 and 2500 analyzing systems in the United States. Dr. Haber is an expert on analytical instrumentation and assay methods and worked for over nine years in R&D at Thermo Electron in Massachusetts (USA).
Read more
Kooperation von PRIMACYT Cell Culture Technology GmbH und Prolytic
08/02/2007
Die PRIMACYT Cell Culture Technology GmbH, Schwerin und die Prolytic GmbH, Frankfurt a.M. haben eine Kooperation beschlossen um zukünftig gemeinsam Wirkstoffe von forschenden Pharmaunternehmen an standardisierten humanen und tierischen Hepatozytenkulturen zu untersuchen.
Read more
Neue Steuereinheit für perzeptive Industriefarbsensoren
07/19/2007
Die Silicann Technologies GmbH wird auf der MOTEK 2007 in Stuttgart vom 24.-27. September der Fachwelt eine neuartige Steuereinheit, die PCS-Control Box, präsentieren. Mit der PCS-Control Box lassen sich die Farben und Parameter der perzeptiven Farbsensoren der PCS-Baureihe der Silicann Technologies GmbH einstellen.
Read more
AIRSENSE liefert weiteres GDA2 an die Feuerwehr Innsbruck aus
07/10/2007
Nach den olympischen Winterspielen in Turin und der Fußball - Weltmeisterschaft 2006 in Frankfurt setzen Feuerwehren bei einem weiteren sportlichen Großereignis auf die Gefahrstoff Detektor - Technik der AIRSENSE Analytics GmbH: Die Feuerwehr Innsbruck, an die AIRSENSE gerade ein weiteres GDA2 ausgeliefert hat, wird das Gerät zur Wahrnehmung ihrer Sicherungsaufgaben bei der Fußball - Europameisterschaft 2008 einsetzen.
Read more
PROPHYTA erhält Zulassung für Contans®WG in Japan
06/29/2007
Die PROPHYTA Biologischer Pflanzenschutz GmbH hat die Zulassung für ihr Produkt Contans®WG in Japan erhalten. Contans®WG, ein biologisches Fungizid zur umweltschonenden Bekämpfung der Sclerotinia-Krankheit an Gemüse und landwirtschaftlichen Kulturpflanzen, soll dort vor allem an Chinakohl, Salat und Melone zur Anwendung kommen. Distributor wird die Firma Ishihara Sangyo Kaisha Ltd..
Read more
GTA provides TeleAtlas with nearly fifty 3D city maps
05/03/2007
Tele Atlas, a leading global provider of digital maps and dynamic content for navigation and location-based solutions, today announced it will make available nearly 50 detailed 3D (three dimensional) city maps for use in navigation devices and location-based applications. The first Tele Atlas 3D city maps will be released in July 2007, including maps for major European cities such as Berlin, London and Rome; additional European, U.S. and Asian cities are scheduled to be released during the next year.
Read more

More news of company